GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » YNBY International Ltd (HKSE:00030) » Definitions » Valuation Rank

YNBY International (HKSE:00030) Valuation Rank


View and export this data going back to 1991. Start your Free Trial

What is YNBY International Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


YNBY International Valuation Rank Related Terms

Thank you for viewing the detailed overview of YNBY International's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


YNBY International Business Description

Traded in Other Exchanges
N/A
Address
979 King’s Road, 32nd Floor, Cambridge Building, Taikoo Place, Quarry Bay, Hong Kong, HKG
YNBY International Ltd is a new-type comprehensive platform for international business development that serves both international and domestic clients. Centering on the health industry, its business covers E-commerce, trading, professional services and healthcare among other things. It operates entities in multiple places across the world and carries out global operations, covering Asia, America and the EMEA region. The company specializes in developing, marketing and promoting healthcare products/ services, ranging from nutraceuticals, pharmaceuticals, and functional food to cosmetics etc in the health industry.
Executives
Luo Ga 2201 Interest of corporation controlled by you
Gold Bricks Holdings Limited 2201 Interest of corporation controlled by you
Huang Bin 2201 Interest of corporation controlled by you
Citic Group Corporation 2201 Interest of corporation controlled by you
Shang Hai Guo Ji Xin Tuo You Xian Gong Si 2301 Trustee
Yun Bai Yao Xiang Gang You Xian Gong Si 2101 Beneficial owner
Yun Nan Bai Yao Ji Tuan Gu Fen You Xian Gong Si 2101 Beneficial owner
Choi Chit Sze, Jackson 2201 Interest of corporation controlled by you
Citic Limited 2201 Interest of corporation controlled by you
Citic International Financial Holdings Limited 2201 Interest of corporation controlled by you
China United International Group Limited 2201 Interest of corporation controlled by you
China Citic Bank Corporation Limited 2201 Interest of corporation controlled by you
Citic International Assets Management Limited 2201 Interest of corporation controlled by you
Sunwah Greatwall Group Limited 2101 Beneficial owner
Radiant Goldstone Holdings Limited 2201 Interest of corporation controlled by you